|
1
|
Huang X, Li X and Xie X, Ye F, Chen B,
Song C, Tang H and Xie X: High expressions of LDHA and AMPK as
prognostic biomarkers for breast cancer. Breast. 30:39–46. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kakushadze Z, Raghubanshi R and Yu W:
Estimating Cost Savings from Early Cancer Diagnosis. SSRN
Electronic J. 2017. View Article : Google Scholar
|
|
4
|
Schootman M, Fuortes L and Aft R:
Prognosis of metachronous contralateral breast cancer according to
stage at diagnosis: The importance of early detection. Breast
Cancer Res Treat. 99:91–95. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bucchi L, Belli P, Benelli E, Bernardi D,
Brancato B, Calabrese M, Carbonaro LA, Caumo F, Cavallo-Marincola
B, Clauser P, et al: Recommendations for breast imaging follow-up
of women with a previous history of breast cancer: Position paper
from the Italian Group for Mammography Screening (GISMa) and the
Italian College of Breast Radiologists (ICBR) by SIRM. Radiol Med.
121:891–896. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Svoronos A, Engelman D and Slack F:
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.
Cancer Res. 76:3666–3670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alhasan AH, Scott AW, Wu JJ, Feng G, Meeks
JJ, Thaxton CS and Mirkin CA: Circulating microRNA signature for
the diagnosis of very high-risk prostate cancer. Proc Natl Acad Sci
USA. 113:pp. 10655–10660. 2016; View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kang J, Kim W, Lee S, Kwon D, Chun J, Son
B, Kim E, Lee JM, Youn H and Youn B: TFAP2C promotes lung
tumorigenesis and aggressiveness through miR-183- and
miR-33a-mediated cell cycle regulation. Oncogene. 36:1585–1596.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pichler M, Stiegelbauer V,
Vychytilova-Faltejskova P, Ivan C, Ling H, Winter E, Zhang X,
Goblirsch M, Wulf-Goldenberg A, Ohtsuka M, et al: Genome-wide
microRNA analysis identifies miR-188-3p as novel prognostic marker
and molecular factor involved in colorectal carcinogenesis. Clin
Cancer Res. 23:1323–1333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hannafon BN, Trigoso YD, Calloway CL, Zhao
YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC and Ding WQ:
Plasma exosome microRNAs are indicative of breast cancer. Breast
Cancer Res. 18:902016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu M, Yang R, Urrehman U, Ye C, Yan X,
Cui S, Hong Y, Gu Y, Liu Y, Zhao C, et al: miR-19b suppresses PTPRG
to promote breast tumorigenesis. Oncotarget. 7:64100–64108.
2016.PubMed/NCBI
|
|
12
|
Li C, Li J, Cai Q, Qiu QQ, Yan M, Liu BY
and Zhu ZG: miRNA-199a-3p: A potential circulating diagnostic
biomarker for early gastric cancer. J Surg Oncol. 108:89–92. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qi Y, Cui L, Ge Y, Shi Z, Zhao K, Guo X,
Yang D, Yu H, Cui L, Shan Y, et al: Altered serum microRNAs as
biomarkers for the early diagnosis of pulmonary tuberculosis
infection. BMC Infect Dis. 12:3842012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adhami M, Haghdoost AA, Sadeghi B and
Malekpour Afshar R: Candidate miRNAs in human breast cancer
biomarkers: A systematic review. Breast Cancer. Nov 3–2017.(Epub
ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ohzawa H, Miki A, Teratani T, Shiba S,
Sakuma Y, Nishimura W, Noda Y, Fukushima N, Fujii H, Hozumi Y, et
al: Usefulness of miRNA profiles for predicting pathological
responses to neoadjuvant chemotherapy in patients with human
epidermal growth factor receptor 2-positive breast cancer. Oncol
Lett. 13:1731–1740. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hemmatzadeh M, Mohammadi H, Jadidi-Niaragh
F, Asghari F and Yousefi M: The role of oncomirs in the
pathogenesis and treatment of breast cancer. Biomed Pharmacother.
78:129–139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mar-Aguilar F, Rodríguez-Padilla C and
Reséndez-Pérez D: Use of serum-circulating miRNA profiling for the
identification of breast cancer biomarkers. Methods Mol Biol.
1165:71–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao
D, Chen G, Li D, Wang X, Cao H, et al: A circulating miRNA
signature as a diagnostic biomarker for non-invasive early
detection of breast cancer. Breast Cancer Res Treat. 154:423–434.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huo D, Clayton WM, Yoshimatsu TF, Chen J
and Olopade OI: Identification of a circulating MicroRNA signature
to distinguish recurrence in breast cancer patients. Oncotarget.
7:55231–55248. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheung CC, Lun SW, Chung GT, Chow C, Lo C,
Choy KW and Lo KW: MicroRNA-183 suppresses cancer stem-like cell
properties in EBV-associated nasopharyngeal carcinoma. BMC Cancer.
16:4952016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gokhale A, Kunder R, Goel A, Sarin R,
Moiyadi A, Shenoy A, Mamidipally C, Noronha S, Kannan S and Shirsat
NV: Distinctive microRNA signature of medulloblastomas associated
with the WNT signaling pathway. J Cancer Res Ther. 6:521–529. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leung WK, He M, Chan AW, Law PT and Wong
N: Wnt/β-Catenin activates miR-183/96/182 expression in
hepatocellular carcinoma that promotes cell invasion. Cancer Lett.
362:97–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rapti S, Kontos CK, Papadopoulos IN and
Scorilas A: High miR-96 levels in colorectal adenocarcinoma predict
poor prognosis, particularly in patients without distant metastasis
at the time of initial diagnosis. Tumour Biol. 37:11815–11824.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu L, Zhong J, Guo B, Zhu Q, Liang H, Wen
N, Yun W and Zhang L: miR-96 promotes the growth of prostate
carcinoma cells by suppressing MTSS1. Tumour Biol. 37:12023–12032.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin H, Dai T, Xiong H, Zhao X, Chen X, Yu
C, Li J, Wang X and Song L: Unregulated miR-96 induces cell
proliferation in human breast cancer by downregulating
transcriptional factor FOXO3a. PLoS One. 5:e157972010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu D, He X, Chang Y, Xu C, Jiang X, Sun S
and Lin J: Inhibition of miR-96 expression reduces cell
proliferation and clonogenicity of HepG2 hepatoma cells. Oncol Rep.
29:653–661. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Haflidadottir BS, Larne O, Martin M,
Persson M, Edsjö A, Bjartell A and Ceder Y: Upregulation of miR-96
enhances cellular proliferation of prostate cancer cells through
FOXO1. PLoS One. 8:e724002013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Song HM, Luo Y, Li DF, Wei CK, Hua KY,
Song JL, Xu H, Maskey N and Fang L: MicroRNA-96 plays an oncogenic
role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in
papillary thyroid carcinoma cells. Int J Clin Exp Pathol.
8:9889–9900. 2015.PubMed/NCBI
|
|
29
|
Gao F and Wang W: MicroRNA-96 promotes the
proliferation of colorectal cancer cells and targets tumor protein
p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1)
and FOXO3a. Mol Med Rep. 11:1200–1206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee YG, Macoska JA, Korenchuk S and Pienta
KJ: MIM, a potential metastasis suppressor gene in bladder cancer.
Neoplasia. 4:291–294. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang XY, Huang ZL, Xu B, Chen Z, Re TJ,
Zheng Q, Tang ZY and Huang XY: Elevated MTSS1 expression associated
with metastasis and poor prognosis of residual hepatitis B-related
hepatocellular carcinoma. J Exp Clin Cancer Res. 35:852016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li XD, Zhang JX, Jiang LJ, Wang FW, Liu
LL, Liao YJ, Jin XH, Chen WH, Chen X, Guo SJ, et al: Overexpression
of maelstrom promotes bladder urothelial carcinoma cell
aggressiveness by epigenetically downregulating MTSS1 through
DNMT3B. Oncogene. 35:6281–6292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li P, Sheng C, Huang L, Zhang H, Huang L,
Cheng Z and Zhu Q: miR-183/-96/-182 cluster is up-regulated in most
breast cancers and increases cell proliferation and migration.
Breast Cancer Res. 16:4732014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guo Y, Ren M, Shang C, Zhu L and Zhong M:
MTSS1 gene regulated by miR-96 inhibits cell proliferation and
metastasis in tongue squamous cellular carcinoma Tca8113 cell line.
Int J Clin Exp Med. 8:15441–15449. 2015.PubMed/NCBI
|
|
36
|
Giacobbe A, Compagnone M,
Bongiorno-Borbone L, Antonov A, Markert EK, Zhou JH,
Annicchiarico-Petruzzelli M, Melino G and Peschiaroli A: p63
controls cell migration and invasion by transcriptional regulation
of MTSS1. Oncogene. 35:1602–1608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kedmi M, Ben-Chetrit N, Körner C, Mancini
M, Ben-Moshe NB, Lauriola M, Lavi S, Biagioni F, Carvalho S,
Cohen-Dvashi H, et al: EGF induces microRNAs that target
suppressors of cell migration: miR-15b targets MTSS1 in breast
cancer. Sci Signal. 8:ra292015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhong J, Shaik S, Wan L, Tron AE, Wang Z,
Sun L, Inuzuka H and Wei W: SCF β-TRCP targets MTSS1 for
ubiquitination-mediated destruction to regulate cancer cell
proliferation and migration. Oncotarget. 4:2339–2353. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hicks DG, Yoder BJ, Short S, Tarr S,
Prescott N, Crowe JP, Dawson AE, Budd GT, Sizemore S, Cicek M, et
al: Loss of breast cancer metastasis suppressor 1 protein
expression predicts reduced disease-free survival in subsets of
breast cancer patients. Clin Cancer Res. 12:6702–6708. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Parr C and Jiang WG: Metastasis suppressor
1 (MTSS1) demonstrates prognostic value and anti-metastatic
properties in breast cancer. Eur J Cancer. 45:1673–1683. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hirata H, Ueno K, Shahryari V, Deng G,
Tanaka Y, Tabatabai ZL, Hinoda Y and Dahiya R: MicroRNA-182-5p
promotes cell invasion and proliferation by down regulating FOXF2,
RECK and MTSS1 genes in human prostate cancer. PLoS One.
8:e555022013. View Article : Google Scholar : PubMed/NCBI
|
